What Does Elevated Troponin Mean in COVID-19?

Allan Jaffe

Ambulatory Blood Pressure Monitoring

William White

Cardiac CT in 2023: From Anatomy to Physiology to Plaque Burden and …

Michael Gallagher

AHA 2022: Chlorthalidone Compared to Hydrochlorothiazide for the Pre…

AHA 2022 Conference Coverage

A. Ishani

ACC 2023: SGLT2i Use - Dos and Don'ts

ACC 2023 Conference Coverage

A. Armbruster

New Insights into Triglyceride Therapy and the Role of Omega-3 Fatty…

National Lipid Association

R. Mason

Which Diuretic(s) Are Best in HF? Update Based on Recent Clinical Tr…

MUSC Cardiology

R. Mentz

ACC 2022: Triple Therapy - When to Use and How Long

ACC 2022 Conference Coverage

D. Kumbhani

SGLT2 Inhibitors: For Heart Failure, Diabetes, and Renal Disease

Rita Jermyn

SGLT2 Inhibitors, GLP1 Receptor Agonists, and Renal Outcomes

Cardiometabolic Health Congress (CMHC)

L. Sloan

Directions of Cardiology in the Next Decade: 2022-2032

Houston Methodist DeBakey Heart and Vascular Center

E. Braunwald

CKD in Primary Care Full Webinar

Springer Healthcare IME

S. Seidu, B. Itzhak, M. Ungan, L. Moist

2020 High Blood Pressure Guidelines: When Is BP Too High?

Houston Methodist DeBakey Heart and Vascular Center

A. Marie Navar

Cardio-Renal Syndrome Management: What Are the Key Factors That Impa…

Patricia Kao

ECG Interpretation: Everything You Need to Know to Understand and In…

Houston Methodist DeBakey Heart and Vascular Center

A. Dave

Neurovascular Mechanisms in Female Sexual Arousal Disorders and Pote…

"Princeton 4: PDE5 Inhibitors and Cardiac Health Symposium.” Huntington Medical Research Institutes, Pasadena, CA. Friday, March 10th, 2023.

N. Kim

EHRA 2024: Ongoing Clinical Investigations with Cardiac Contractilit…

CCM® Therapy

N. Varma

EHRA 2024: Real-World Experience with Cardiac Contractility Modulati…

CCM® Therapy

J. Kuschyk

EHRA 2024: Cardiac Contractility Modulation: Innovative Therapy for …

CCM® Therapy

V. Reddy, N. Varma, K. Kuck, J. Kuschyk, N. Aspromonte